Baird Financial Group, Inc. Sarepta Therapeutics, Inc. Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $470 - $623	4 Added 0.26%	1,554 $214,000
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $74,574 - $117,451	-985 Reduced 22.56%	3,381 $374,000
Q2 2022 Aug 08, 2022	SELL	$62.69 - $88.44 $109,895 - $155,035	-1,753 Reduced 28.65%	4,366 $327,000
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $70,664 - $101,179	-1,119 Reduced 15.46%	6,119 $478,000
Q4 2021 Feb 09, 2022	SELL	$77.28 - $99.42 $14,142 - $18,193	-183 Reduced 2.47%	7,238 $652,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $108,190 - $151,667	1,640 Added 28.37%	7,421 $686,000
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $42,668 - $53,351	615 Added 11.9%	5,781 $449,000
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $58,233 - $136,173	806 Added 18.49%	5,166 $385,000
Q4 2020 Feb 11, 2021	SELL	$125.56 - $178.74 $47,085 - $67,027	-375 Reduced 7.92%	4,360 $743,000
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $32,161 - $43,602	253 Added 5.64%	4,735 $665,000
Q2 2020 Oct 22, 2020	SELL	$93.0 - $171.7 $103,788 - $191,617	-1,116 Reduced 19.94%	4,482 $719,000
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $46,779 - $86,365	503 Added 9.87%	5,598 $722,000
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $44,979 - $71,875	546 Added 12.0%	5,095 $498,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $105,075 - $186,151	1,373 Added 43.23%	4,549 $587,000
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $114,748 - $247,290	1,576 Added 98.5%	3,176 $239,000
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $179,536 - $243,119	1,600 New	1,600 $244,000
Q2 2018 Aug 13, 2018	SELL	$71.74 - $153.69 $215,578 - $461,838	-3,005 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$54.02 - $82.27 $306,995 - $467,540	-5,683 Reduced 65.41%	3,005 $223,000
Q4 2017 Feb 09, 2018	SELL	$47.64 - $56.75 $56,167 - $66,908	-1,179 Reduced 11.95%	8,688 $483,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $35,658 - $47,055	998 Added 11.25%	9,867 $448,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,869	8,869 $299,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.23 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.07 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$745 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$519 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$508 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account